Press Releases

This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.

Date Title
08/15/19
Summary ToggleQuest Diagnostics Declares Quarterly Cash Dividend SECAUCUS, N.J. , Aug. 15, 2019 /PRNewswire/ -- Quest Diagnostics  (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on October 21, 2019 to shareholders of record Printer Friendly Version
07/23/19
Summary ToggleQuest Diagnostics Reports Second Quarter 2019 Financial Results - Second quarter revenues of $1.95 billion, up 1.8% from 2018 - Second quarter reported diluted earnings per share from continuing operations ("EPS") of $1.51, down 3.9% from 2018; and adjusted diluted EPS of $1.73, down 1.1% from 2018 - Affirms outlook for full-year 2019 SECAUCUS, N.J. Printer Friendly Version
07/18/19
Summary ToggleQuest Diagnostics Welcomes New Members to the Global Diagnostics Network (GDN) Two new companies join the GDN, expanding this novel worldwide network of leading diagnostics service providers With nine members spanning the globe, the GDN has a presence in countries covering two-thirds of the world's population, and over 90% of the global pharmaceutical market SECAUCUS, N.J. Printer Friendly Version
07/17/19
Summary ToggleQuest Diagnostics Named one of the "Best Places to Work for Disability Inclusion" SECAUCUS, N.J. , July 17, 2019 /PRNewswire/ --  Quest Diagnostics  (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has been named to the 2019 Disability Equality Index (DEI) "Best Places to Work for Disability Inclusion" by Disability:IN and the Printer Friendly Version
07/17/19
Summary ToggleCatholic Health Services Partners with Quest Diagnostics to Deliver High-Value, Innovative Laboratory Services SECAUCUS, N.J. and ROCKVILLE CENTRE, N.Y. , July 17, 2019 /PRNewswire/ -- Catholic Health Services (CHS), an integrated health care delivery system with a 24% market share on Long Island , is teaming up with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information Printer Friendly Version
07/09/19
Summary ToggleQuest Diagnostics To Release Second Quarter 2019 Financial Results On July 23 SECAUCUS, N.J. , July 9, 2019 /PRNewswire/ --  Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2019 results on Tuesday, July 23, 2019 , before the market opens. Printer Friendly Version
06/17/19
Summary ToggleEmployer Wellness Screening with Digital Diabetes Prevention Program May Lower Eight-Year Risk of Diabetes, Suggests Quest Diagnostics Study Participants decreased diabetes risk by 2.8 percent on average and 31 percent lost five percent or more of body weight after completing at least nine lessons in program SECAUCUS, N.J. , June 17, 2019 /PRNewswire/ -- Individuals with prediabetes who participate in an employer-sponsored digital Printer Friendly Version
05/29/19
Summary ToggleQuest Diagnostics Now Participating in NCI-MATCH Precision Medicine Clinical Trial As the leader in Advanced Diagnostics, including Next Generation Sequencing (NGS), Quest joins a select group of commercial and academic laboratories to meet the rigorous requirements for participation in this clinical trial Both the Quest Med Fusion 50SEQ cancer panel and IBM Watson Genomics from Printer Friendly Version
05/14/19
Summary ToggleQuest Diagnostics Declares Quarterly Cash Dividend SECAUCUS, N.J. , May 14, 2019 /PRNewswire/ -- Quest Diagnostics  (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on July 22, 2019 to shareholders of record Printer Friendly Version
05/13/19
Summary ToggleQuest Diagnostics To Speak At The UBS Global Healthcare Conference SECAUCUS, N.J. , May 13, 2019 /PRNewswire/ --  Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS Global Healthcare Conference in New York.  Steve Rusckowski , Chairman, President and CEO Printer Friendly Version
04/23/19
Summary ToggleQuest Diagnostics Reports First Quarter 2019 Financial Results - First quarter revenues of $1.89 billion, up 0.4% from 2018 - First quarter reported diluted EPS of $1.20, down 5.4% from 2018; and adjusted diluted EPS of $1.40, down 7.9% from 2018 - Cash provided by operations was $275 million, up 53.4% from 2018 - Outlook for full-year 2019 remains unchanged. Printer Friendly Version
04/22/19
Summary ToggleForbes Names Quest Diagnostics One of America's Best Large Employers SECAUCUS, N.J. , April 22, 2019 /PRNewswire/ --  Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it was selected by Forbes as one of America's Best Large Employers of 2019.  Quest was among one of only fifteen Printer Friendly Version
04/18/19
Summary ToggleQuest Diagnostics Launches New Consumer-Initiated STD Tests Through QuestDirect™ Available nationwide, the new services link consumer-initiated testing with medical oversight and counsel to help combat the nation's record rate of STDs SECAUCUS, N.J. , April 18, 2019 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, Printer Friendly Version
04/11/19
Summary ToggleWorkforce Drug Testing Positivity Climbs to Highest Rate Since 2004, According to New Quest Diagnostics Analysis Analysis of more than ten million workplace drug test results shows increases in marijuana positivity across nearly all employee testing categories Increases in post-accident positivity in the general U.S. workforce outpace those for all other testing reasons, including pre-employment screening Printer Friendly Version
04/04/19
Summary ToggleQuest Diagnostics To Release First Quarter 2019 Financial Results On April 23 SECAUCUS, N.J. , April 4, 2019 /PRNewswire/ --  Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2019 results on Tuesday, April 23, 2019 , before the market opens. Printer Friendly Version
04/03/19
Summary ToggleQuest Diagnostics Presents Supplier Excellence Awards to Four Partners SECAUCUS, N.J. , April 3, 2019 /PRNewswire/ -- Quest Diagnostics  (NYSE: DGX), the world's leading provider of diagnostic information services, today awarded Supplier Excellence awards to four companies at its 2019 Supplier Forum . Supplier Excellence awards recognize world-class products, systems, Printer Friendly Version
04/01/19
Summary ToggleQuest Diagnostics Achieves Perfect Score On 2019 Human Rights Campaign Corporate Equality Index for Third Consecutive Year SECAUCUS, N.J. , April 1, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, received a perfect score of 100 from the Human Rights Campaign Foundation on the 2019 Corporate Equality Index, earning the distinction of Printer Friendly Version
04/01/19
Summary ToggleMassachusetts Governor Baker Visits State of the Art Quest Diagnostics Marlborough Laboratory MARLBOROUGH, Mass. , April 1, 2019 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, hosted Massachusetts Governor Charlie Baker at its state-of-the-art clinical testing laboratory in Marlborough, Massachusetts on Friday, March 29.  Printer Friendly Version
03/26/19
Summary ToggleQuest Diagnostics to Present New Insights from Genetic Testing at the 2019 Annual American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting Eight presentations highlight Quest's Advanced Diagnostics testing and research insights into hereditary genetics SECAUCUS, N.J. , March 26, 2019 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will present Printer Friendly Version
03/07/19
Summary ToggleQuest Diagnostics Prices $500 Million of Senior Notes SECAUCUS, N.J. , March 7, 2019 /PRNewswire/ --  Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $500 million aggregate principal amount of its 4.200% senior notes due 2029 under the Printer Friendly Version
03/07/19
Summary ToggleQuest Diagnostics To Speak At The Barclays Global Healthcare Conference SECAUCUS, N.J. , March 7, 2019 /PRNewswire/ --  Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Barclays Global Healthcare Conference in Miami.  Mark Guinan , Executive Vice President and CFO Printer Friendly Version
03/01/19
Summary ToggleQuest Diagnostics Declares Quarterly Cash Dividend SECAUCUS, N.J. , March 1, 2019 /PRNewswire/ -- Quest Diagnostics  (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on April 22, 2019 to shareholders of record Printer Friendly Version
02/27/19
Summary ToggleRMC and Quest Diagnostics to Deliver High-Value, Innovative Lab Services SECAUCUS , N.J. and ORANGEBURG, S.C. , Feb. 27, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Regional Medical Center (RMC) of Orangeburg, S.C. , are teaming up to enhance the quality and value of diagnostic services for Printer Friendly Version
02/20/19
Summary ToggleQuest Diagnostics Partners With Houston Healthcare to Deliver High-Value, Innovative Laboratory Services SECAUCUS , N.J. and WARNER ROBINS, Ga. , Feb. 20, 2019 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Houston Healthcare are teaming up to enhance the quality and value of diagnostic services to patients and their doctors through Printer Friendly Version
02/19/19
Summary ToggleQuest Diagnostics Elects Denise Morrison to Board of Directors SECAUCUS, N.J. , Feb. 19, 2019 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Denise M. Morrison to serve as a director, effective February 18 , 2019.  Including Ms. Printer Friendly Version
02/18/19
Summary ToggleQuest Diagnostics Names Gabrielle Wolfson Senior Vice President and Chief Information and Digital Officer SECAUCUS, N.J. , Feb. 18, 2019 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that Gabrielle Wolfson, a veteran information technology business leader, has been named Senior Vice President and Chief Information and Printer Friendly Version
02/14/19
Summary ToggleQuest Diagnostics Reports Fourth Quarter And Full Year 2018 Financial Results; Provides Guidance For Full Year 2019 - Fourth quarter revenues of $1.84 billion, down 1.4% versus 2017 - Fourth quarter diluted EPS of $0.92 on a reported basis, down 49.5% from 2017 which included a tax benefit recorded as a result of the Tax Cuts and Jobs Act (TCJA); and $1.36 on an adjusted basis excluding amortization, down 2.9% Printer Friendly Version
02/11/19
Summary ToggleQuest Diagnostics Completes Acquisition of Laboratory Services Business of Boyce & Bynum Pathology Laboratories Transaction expands access to diagnostic innovations in clinical and pathology services for patients, physicians and hospitals throughout Missouri and surrounding Midwestern states SECAUCUS, N.J. and COLUMBIA, Mo. , Feb. 11, 2019 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading Printer Friendly Version
01/22/19
Summary ToggleQuest Diagnostics Named One of 2019 "World's Most Admired Companies" by Fortune Magazine for Fourth Consecutive Year SECAUCUS, N.J. , Jan. 22, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2019 for the fourth consecutive year.  The annual survey Printer Friendly Version
01/14/19
Summary ToggleMore Adults Know Their Multidigit Wi-Fi Password Than Vital Health Information, Including Their Single-Letter Blood Type Nearly Six in Ten Recognize Access to Health Vitals is Important in an Emergency, Yet Nearly 30 Percent Keep Lab Results in a File Cabinet at Home Challenges Retaining and Accessing Key Medical Information are Key Drivers to This Lack of Knowledge SECAUCUS, N.J. , Jan. Printer Friendly Version